![Xu Wei](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Xu Wei
Director/Board Member at AnHeart Therapeutics (Hangzhou) Co., Ltd.
Xu Wei active positions
Companies | Position | Start | End |
---|---|---|---|
AnHeart Therapeutics (Hangzhou) Co., Ltd.
![]() AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | Director/Board Member | - | - |
Career history of Xu Wei
Statistics
International
China | 2 |
Operational
Director/Board Member | 1 |
Sectoral
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
AnHeart Therapeutics (Hangzhou) Co., Ltd.
![]() AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | Commercial Services |
- Stock Market
- Insiders
- Xu Wei
- Experience